Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M.L. Navarro Gómez is active.

Publication


Featured researches published by M.L. Navarro Gómez.


Anales De Pediatria | 2009

Exposición a antirretrovirales y crecimiento en una cohorte de niños no infectados, hijos de madre con VIH positivo

M. Fernández Ibieta; J.M. Bellón Cano; J.T. Ramos Amador; María Isabel González-Tomé; S. Guillén Martín; M.L. Navarro Gómez; M.I. de José; José Beceiro; E. Iglesias; Luis Prieto; M.J. Santos; N. Martínez Guardia; M.A. Roa; J. Regidor

INTRODUCTION Recent reports show that Antiretroviral Treatment (ART) during pregnancy does not affect somatic growth of children born to HIV-infected mothers, are reassuring. The aim of this study is to perform an anthropometric analysis of the uninfected children followed in the Spanish FIPSE cohort during their first 18 months of life, and to describe the possible risk factors during pregnancy that may influence low birth weight. METHODS The FIPSE cohort includes 8 public hospitals in Madrid, and prospectively follows children born to HIV-infected women at these hospitals. We collected data on 601 uninfected children, following standardised protocols, during their first 2 years of life. A P value<0.05 was considered statistically significant. Data from the Pablo Orbegozo Foundation were used to compare the means of our population with the standard weight, longitude an occipitofrontal circumference (OFC) of the Spanish population during the first 18 months of life. RESULTS The mean weight was 2766g (+/-590), and 2967g (+/-427) when premature neonates were excluded. The proportion of Intrauterine Growth Restriction among non- premature neonates was 19.8% (95% CI: 16.3-23.8). Children born to mothers that used illicit drugs weighed less: 2752g (+/-325) vs. 3002g (+/ 435), P<0.001, as did children born to mothers who smoked during pregnancy: 2842g (+/-363) vs. 3018g (+/-444), P>0.001. Maternal anaemia did not influence the low birth weight of the children when premature neonates were excluded. We found no statistically significant differences depending on the ART received during pregnancy. Children born to mothers who had CD4 > 500 cell /mm were heavier (2834g +/-503) than those whose mothers had CD4 of less than 200 cell/mm (2565g +/-702), P=0.008. These differences disappeared when premature neonates were excluded. Children born to mothers with undetectable viral load were heavier (2866g +/-532 vs. 2704g +/-588, P=0.005), but these differences also disappeared when the prematures were excluded from the analysis. Mean weight, length, and OFC of our population at birth (excluding premature neonates) were lower than the Spanish standards. (z for weight=-0.83; z for length =-1.02; z for OFC=-1.00), but these differences are not statistically significant and disappear at 18 months of age (z for weight=-0.08; z for height=-0.32; z for OFC=-0.31). The type of ART did not have any significant influence. DISCUSSION There is a very significant difference between the weight of the children born to mothers addicted to illicit drugs and the rest of the children. Similarly, the weight of the children born to smoking mothers is significantly lower. There was no association between maternal anaemia and the type of ART. The children of our population have lower weights, length and OFC at birth, but this may due to the high number of scheduled caesarean births, practised at 38 weeks of pregnancy (54.5%). Our children catch-up with anthropometric measurements during the first and second year of life, and these are similar to Spanish standards at 18 months old.


Anales De Pediatria | 2014

Serotipos no vacunales emergentes causantes de enfermedad neumocócica invasora en la era de la vacuna 7-valente

F. González Martínez; M.L. Navarro Gómez; J. Saavedra Lozano; M. M. Santos Sebastián; R. Rodríguez Fernández; M. González Sánchez; E. Cercenado Mansilla; T. Hernández-Sampelayo Matos

INTRODUCTION There has been an increased incidence in invasive pneumococcal disease (IPD) produced by non-vaccine serotype (NVS) of Streptococcus pneumoniae after the introduction of PCV7. Our objective was to describe the epidemiological, clinical and microbiological characteristics of IPD caused by NVS in a tertiary hospital in Madrid. PATIENTS AND METHODS Retrospective (1998-2004) and prospective (2005-2009) study evaluating IPD caused by NVS in children. The study was divided into three periods: P1 (1998-2001) when PCV7 was not commercialized; P2 (2002-2005) with 40% vaccine coverage among children; and P3 (2006-2009) when the vaccine was added to the Childhood Immunization Schedule in Madrid. RESULTS We analyzed 155 cases of IPD. One hundred and fifty of these isolates were serotyped (100 were NVS). There was an increase in the prevalence of IPD from P1 (31%) to P2 (54%) and P3 (91%). The most relevant emerging serotypes were 19A, 7F, 1, 5, 3 and 15C. The most significant clinical syndromes produced by some specific serotypes were as follows: lower respiratory tract infection (LRTI) by serotypes 1, 3, 5 and 15C; LRTI, primary bacteremia and meningitis by serotype 19A; and primary bacteremia by serotype 7F (66%). The large majority (83.8%) of NVS were sensitive to penicillin. CONCLUSIONS There has been an increased prevalence of IPD caused by NVS since the introduction of PCV7. These changes should prompt the introduction of new pneumococcal vaccines, which include most of the NVS, in the childhood immunization calendar to prevent IPD in children.


Anales De Pediatria | 2015

Guía de la Sociedad Española de Infectología Pediátrica sobre tuberculosis en la embarazada y el recién nacido (I): epidemiología y diagnóstico. Tuberculosis congénita

F. Baquero-Artigao; M.J. Mellado Peña; T. del Rosal Rabes; A. Noguera Julián; A. Goncé Mellgren; M. de la Calle Fernández-Miranda; M.L. Navarro Gómez

Tuberculosis (TB) screening in pregnancy using tuberculin skin test (TST) is recommended in case of symptoms of TB disease, close contact with a patient with infectious TB, or high risk of developing active disease. The new interferon gamma release assay (IGRA) tests are recommended in BCG-vaccinated pregnant women with positive TST and no known risk factors for TB, and in those immunocompromised, with clinical suspicion of TB but negative TST. TB diagnosis is difficult due to the non-specific symptoms, the increased frequency of extrapulmonary disease, the delay in radiological examinations, and the high rate of tuberculin anergy. Neonatal TB can be acquired in utero (congenital TB), or through airborne transmission after delivery (postnatal TB). Congenital TB is extremely rare and does not cause fetal malformations. It may be evident at birth, although it usually presents after the second week of life. In newborns with no family history of TB, the disease should be considered in cases of miliary pneumonia, hepatosplenomegaly with focal lesions, or lymphocytic meningitis with hypoglycorrhachia, especially in those born to immigrants from high TB-burden countries. TST is usually negative, and IGRAs have lower sensitivity than in older children. However, the yield of acid-fast smear and culture is higher, mostly in congenital TB. Molecular diagnosis techniques enable early diagnosis and detection of drug resistance mutations. There is a substantial risk of disseminated disease and death.


Anales De Pediatria | 2015

Guía de la Sociedad Española de Infectología Pediátrica sobre tuberculosis en la embarazada y el recién nacido (ii): profilaxis y tratamiento

F. Baquero-Artigao; M.J. Mellado Peña; T. del Rosal Rabes; A. Noguera Julián; A. Goncé Mellgren; M. de la Calle Fernández-Miranda; M.L. Navarro Gómez

In pregnant women who have been exposed to tuberculosis (TB), primary isoniazid prophylaxis is only recommended in cases of immunosuppression, chronic medical conditions or obstetric risk factors, and close and sustained contact with a patient with infectious TB. Isoniazid prophylaxis for latent tuberculosis infection (LTBI) is recommended in women who have close contact with an infectious TB patient or have risk factors for progression to active disease. Otherwise, it should be delayed until at least three weeks after delivery. Treatment of TB disease during pregnancy is the same as for the general adult population. Infants born to mothers with disseminated or extrapulmonary TB in pregnancy, with active TB at delivery, or with postnatal exposure to TB, should undergo a complete diagnostic evaluation. Primary isoniazid prophylaxis for at least 12 weeks is recommended for those with negative diagnostic tests and no evidence of disease. Repeated negative diagnostic tests are mandatory before interrupting prophylaxis. Isoniazid for 9 months is recommended in LTBI. Treatment of neonatal TB disease is similar to that of older children, but should be maintained for at least 9 months. Respiratory isolation is recommended in congenital TB, and in postnatal TB with positive gastric or bronchial aspirate acid-fast smears. Separation of mother and infant is only necessary when the mother has received treatment for less than 2 weeks, is sputum smear-positive, or has drug-resistant TB. Breastfeeding is not contraindicated, and in case of mother-infant separation expressed breast milk feeding is recommended.


Anales De Pediatria | 2013

Aumento de la incidencia de enfermedad neumocócica invasora producida por el serotipo 19A previo a la introducción de las vacunas neumocócicas ampliadas

F. González Martínez; J. Saavedra Lozano; M.L. Navarro Gómez; M. M. Santos Sebastián; R. Rodríguez Fernández; M. González Sánchez; T. Hernández-Sampelayo Matos

OBJECTIVE To describe the epidemiology, clinical syndromes and microbiological characteristics of serotype 19A as the main cause of invasive pneumococcal disease (IPD) in children admitted to a tertiary hospital in Spain. METHODS A retrospective (1998-2004) and prospective (2005-2009) study was conducted on children with IPD produced by serotype 19A. The study was divided into three periods (P): P1 (1998-2001) when PCV7 had not been commercialized; P2 (2002-2005) with 40% vaccine coverage among children; and P3 (2006-2009) when the vaccine was added to the Childhood Immunization Schedule in Madrid. RESULTS A total of 155 isolates of Streptococcus pneumoniae (SP) producing IPD were analysed, with 21 of them being serotype 19A (14%). An increased prevalence of serotype 19A was found: 2/45 cases (4.4%) in P1, 3/41 cases (7.3%) in P2 and 16/69 cases (23.2%) in P3. It occurred mostly in children younger than 2 years (16/21; 76%). This serotype was the main cause of meningitis (5/20; 25%), pleural empyema (3/22; 14%) and bacteraemic mastoiditis (2/4; 50%). Thirteen isolates (61.5%) had an MIC ≥ 0.12μ/ml for penicillin in extra-meningeal infections, and 3 of the 5 isolates causing meningitis (60%) had an MIC ≥ 1μ/ml for cefotaxime. CONCLUSIONS Serotype 19A was the main causal agent of IPD in the PCV7 era (P3), with high antibiotic resistance rates. This serotype was responsible for all types of IPD, being the main cause of meningitis.


Anales De Pediatria | 2005

Absceso cerebral infantil

R. Borrego Domínguez; M.L. Navarro Gómez; Ja Gómez-Campderá; J Carreras Fernández

Introduccion El absceso cerebral es una infeccion poco frecuente en la infancia pero de una alta morbimortalidad que actualmente ha disminuido gracias al diagnostico precoz debido a los avances en la imagen neurorradiologica y a las mejoras en la antibioterapia. Se describen 6 casos diagnosticados y seguidos en el Hospital Infantil Gregorio Maranon de Madrid desde enero de 1996 hasta septiembre de 2003. Metodos Se analizan de forma retrospectiva las historias clinicas recogiendose la edad, sexo, manifestaciones clinicas, exploracion, estudio radiologico, etiologia, tratamiento y evolucion clinica de los mismos. Resultados La edad de los pacientes se encuentra comprendida entre 8 y 15 anos (media: 11 anos); tres de ellos eran mujeres y 3 varones. Predominaron las manifestaciones neurologicas y cuatro de ellos tenian infeccion otorrinolaringologica asociada (sinusitis), uno cardiopatia cianogena y otro una meningitis. El diagnostico se efectuo mediante tomografia computarizada (TC) en 5 casos y en uno mediante resonancia magnetica (RM). La localizacion fue en 5 casos frontal y el tratamiento en todos ellos se realizo mediante antibioterapia de amplio espectro necesitando abordaje quirurgico cinco de ellos. Dos pacientes tuvieron secuelas neurologicas. Conclusiones Aunque el absceso cerebral es infrecuente hay que tenerlo en cuenta ante sintomas neurologicos asociados a la infeccion otorrinolaringologica o cardiopatia cianogena, debiendose realizar una TC (o RM) y, tratandose con antibioticos de amplio espectro y en algunos casos drenaje quirurgico.


Anales De Pediatria | 2010

Exposición a antirretrovirales y toxicidad mitocondrial en una cohorte de niños no infectados hijos de madres VIH positivas

M. Fernández Ibieta; J.M. Bellón Cano; J.T. Ramos Amador; María Isabel González-Tomé; S. Guillén Martín; M.L. Navarro Gómez; M.I. de José; José Beceiro; E. Iglesias; Luis Prieto; M.J. Santos; N. Martínez Guardia; M.A. Roa; J. Regidor

INTRODUCTION In this study, we attempt to find out the percentage of uninfected infants born to HIV-infected women and exposed in-utero and perinatally to Antiretroviral Treatment (ART) that show high lactate levels, or any other mitochondrial damage markers (such as hypertransaminasaemia or hyperamylasaemia), during the first three months of age. We shall also establish whether certain drugs used in-utero are associated with higher lactate, transaminase or amylase levels. METHODS We analysed the available data from 623 uninfected infants born in the Spanish FIPSE cohort that were born in the period 2000-2005. The normal values for lactate, transaminases and amylase were set according to AIDS Clinical Groups Trials toxicity tables for infants. RESULTS The percentages of children with high lactate levels at 0.5; 1.5 and 3 months of age were 48%, 51.4% and 43% among those infants with available data. Respectively, the percentages of children with high AST values were 13.2; 10.4 and 17.2%. The values for high ALT were 3.3%; 3.4% and 5%. The percentages for hyperamylasaemia were 0%; 0.6% and 2.6%. We found no significant difference among the drugs used in utero for the four analysed biochemical markers along the first three months of age. CONCLUSIONS We have found a high proportion of hyperlactataemia among infants exposed in-utero to ART, as shown in other cohorts of similar characteristics. No morbidity or mortality was communicated to the cohort analysis group. No ART drug among those used in-utero was statistically associated with a higher proportion of high lactate levels in these infants.


Anales De Pediatria | 2002

Coinfección por Chlamydia y Mycoplasma. Incidencia en nuestro medio

A. Megías Montijano; J.A. Gómez Campderá; M.L. Navarro Gómez; M. Urán Moreno; M. González Sánchez; R. Rodríguez Fernández

Objetivos Investigar la presencia y determinar la importancia de Chlamydia pneumoniae y Mycoplasma pneumoniae como copatogenos de las neumonias comunitarias en la infancia. Material y metodos Estudio retrospectivo descriptivo, de todos los casos diagnosticados de neumonia por M. pneumoniae en menores de 15 anos, en el servicio de urgencias de pediatria, en el periodo comprendido entre mayo de 1998 y mayo de 2000, investigando aquellos casos en los que se pudo demostrar la coexistencia con C. pneumoniae. Resultados Sobre un total de 242 neumonias diagnosticadas durante este periodo de tiempo, 84 fueron causadas por M. pneumoniae (34,7 %) y 32 por C. pneumoniae (13,22 %); de ellas, 8 casos presentaron coinfeccion por C. pneumoniae y M. pneumoniae. Existio predominio en el sexo masculino 5/8, con una edad media al diagnostico de 7,7 anos. No hubo predominio estacional. Conclusiones Tanto C. pneumoniae como M. pneumoniae son responsables de Neumonia Adquirida en la Comunidad en ninos mayores de 5 anos. A pesar del hecho de que las coinfecciones por C. pneumoniae y M. pneumoniae se acompanan normalmente de agravamiento en el curso de la enfermedad, todos los casos estudiados evolucionaron satisfactoriamente.


Anales De Pediatria | 2005

Espondilodiscitis en la Comunidad de Madrid

B. Rubio Gribble; C. Calvo Rey; J. Garcia-Consuegra; L. Ciria Calabria; M.L. Navarro Gómez; J.T. Ramos Amador


Anales De Pediatria | 2011

Documento de consenso de la Sociedad Española de Infectología Pediátrica y el Comité Asesor de Vacunas de la Asociación Española de Pediatría para la vacunación en inmunodeprimidos

M.J. Mellado Peña; D. Moreno-Pérez; J. Ruiz Contreras; T. Hernández-Sampelayo Matos; M.L. Navarro Gómez

Collaboration


Dive into the M.L. Navarro Gómez's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

J.A. Gómez Campderá

Autonomous University of Madrid

View shared research outputs
Top Co-Authors

Avatar

M.I. de José

Hospital Universitario La Paz

View shared research outputs
Top Co-Authors

Avatar

T. del Rosal Rabes

Hospital Universitario La Paz

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M.J. Mellado Peña

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

C. Calvo Rey

Instituto de Salud Carlos III

View shared research outputs
Researchain Logo
Decentralizing Knowledge